NCT03907137 - Real World Study With Benralizumab in Severe Asthma in Switzerland | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 21, 2019

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2023

Conditions

Severe Eosinophilic Asthma

Trial Locations (12)

Research Site, Geneva

Research Site, Sion

Research Site, Bern

Research Site, Basel

Research Site, Liestal

Research Site, Lucerne

Research Site, Chur

Research Site, Zurich

Research Site, Zurich

Research Site, Zurich

Research Site, Aathal

Research Site, Wetzikon